Real-world outcomes in hereditary angioedema: first experience from the Icatibant Outcome Survey in the United Kingdom
Abstract Background Hereditary angioedema (HAE) is a potentially life-threatening, bradykinin-mediated disease, often misdiagnosed and under-treated, with long diagnostic delays. There are limited real-world data on best-practice management of HAE in the UK. Objectives To characterize the clinical p...
Main Authors: | Hilary J. Longhurst, John Dempster, Lorena Lorenzo, Matthew Buckland, Sofia Grigoriadou, Christine Symons, Claire Bethune, Vincent Fabien, Catherine Bangs, Tomaz Garcez |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2018-08-01
|
Series: | Allergy, Asthma & Clinical Immunology |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13223-018-0253-x |
Similar Items
-
Breakthrough attacks in patients with hereditary angioedema receiving long-term prophylaxis are responsive to icatibant: findings from the Icatibant Outcome Survey
by: Werner Aberer, et al.
Published: (2017-07-01) -
Effectiveness of icatibant for treatment of hereditary angioedema attacks is not affected by body weight: findings from the Icatibant Outcome Survey, a cohort observational study
by: Teresa Caballero, et al.
Published: (2018-03-01) -
Elderly versus younger patients with hereditary angioedema type I/II: patient characteristics and safety analysis from the Icatibant Outcome Survey
by: Anette Bygum, et al.
Published: (2019-07-01) -
Optimum Use of Acute Treatments for Hereditary Angioedema: Evidence-Based Expert Consensus
by: Hilary Longhurst
Published: (2018-03-01) -
Management of hereditary angioedema in Japan: Focus on icatibant for the treatment of acute attacks
by: Michihiro Hide, et al.
Published: (2021-01-01)